Erythematous Rosacea
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% (NCT00697541) | Galderma R&D | 2008-05-01 |
Track Erythematous Rosacea automatically
Every clearance here is in the API, with alerts when new ones post.